SCG2
secretogranin II, the group of Granins
Basic information
Region (hg38): 2:223596939-223602361
Links
Phenotypes
GenCC
Source:
No genCC data.
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (14 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SCG2 gene is commonly pathogenic or not.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | 1 | ||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice variant | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 0 | 1 |
Variants in SCG2
This is a list of pathogenic ClinVar variants found in the SCG2 region.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-223597489-G-A | Benign (Apr 10, 2018) | |||
2-223597613-T-A | Inborn genetic diseases | Uncertain significance (Feb 11, 2022) | ||
2-223597769-C-A | Inborn genetic diseases | Uncertain significance (Oct 26, 2021) | ||
2-223597813-T-A | Inborn genetic diseases | Uncertain significance (Nov 10, 2022) | ||
2-223597892-G-A | Inborn genetic diseases | Uncertain significance (Aug 17, 2021) | ||
2-223598001-G-T | Inborn genetic diseases | Uncertain significance (Mar 21, 2023) | ||
2-223598034-T-C | Inborn genetic diseases | Uncertain significance (Jul 12, 2022) | ||
2-223598063-T-C | Inborn genetic diseases | Uncertain significance (Jul 12, 2023) | ||
2-223598171-G-A | Inborn genetic diseases | Uncertain significance (Oct 25, 2022) | ||
2-223598336-C-G | Inborn genetic diseases | Uncertain significance (Jul 26, 2021) | ||
2-223598351-A-T | Inborn genetic diseases | Uncertain significance (Aug 04, 2023) | ||
2-223598473-C-A | Inborn genetic diseases | Uncertain significance (Jun 27, 2022) | ||
2-223598492-T-C | Inborn genetic diseases | Uncertain significance (Apr 28, 2023) | ||
2-223598577-C-T | Inborn genetic diseases | Uncertain significance (Dec 20, 2021) | ||
2-223598626-C-A | Inborn genetic diseases | Uncertain significance (Jun 22, 2021) | ||
2-223598876-G-A | Inborn genetic diseases | Uncertain significance (Jul 14, 2023) | ||
2-223598911-C-A | Inborn genetic diseases | Uncertain significance (Sep 06, 2022) | ||
2-223598961-C-G | Inborn genetic diseases | Uncertain significance (Jan 26, 2023) | ||
2-223599140-T-C | Inborn genetic diseases | Uncertain significance (Apr 08, 2022) | ||
2-223599190-C-G | Inborn genetic diseases | Uncertain significance (Sep 27, 2022) | ||
2-223599259-C-A | Inborn genetic diseases | Uncertain significance (Dec 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SCG2 | protein_coding | protein_coding | ENST00000305409 | 1 | 5564 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000212 | 0.978 | 125723 | 0 | 24 | 125747 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0751 | 320 | 316 | 1.01 | 0.0000162 | 4123 |
Missense in Polyphen | 87 | 98.881 | 0.87985 | 1370 | ||
Synonymous | -0.529 | 126 | 119 | 1.06 | 0.00000636 | 1112 |
Loss of Function | 2.07 | 11 | 21.3 | 0.516 | 0.00000110 | 279 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000476 | 0.000475 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Secretogranin-2 is a neuroendocrine secretory granule protein, which is the precursor for biologically active peptides.;
- Pathway
- Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
(Consensus)
Recessive Scores
- pRec
- 0.423
Intolerance Scores
- loftool
- 0.349
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.76
Haploinsufficiency Scores
- pHI
- 0.839
- hipred
- Y
- hipred_score
- 0.553
- ghis
- 0.549
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.449
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Scg2
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- MAPK cascade;angiogenesis;negative regulation of endothelial cell proliferation;positive regulation of endothelial cell proliferation;inflammatory response;protein secretion;regulation of signaling receptor activity;intracellular signal transduction;endothelial cell migration;post-translational protein modification;cellular protein metabolic process;eosinophil chemotaxis;positive chemotaxis;induction of positive chemotaxis;negative regulation of endothelial cell apoptotic process;negative regulation of extrinsic apoptotic signaling pathway
- Cellular component
- extracellular space;endoplasmic reticulum lumen;secretory granule;neuronal dense core vesicle
- Molecular function
- cytokine activity;protein binding;chemoattractant activity